Literature DB >> 7983976

Longlasting improvement of Tourette's syndrome with transdermal nicotine.

S M Dursun, M A Reveley, R Bird, F Stirton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7983976     DOI： 10.1016/s0140-6736(94)90388-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder.

Authors:  Fiona C Crawford; Ghania Ait-Ghezala; Mark Morris; Maxine J Sutcliffe; Robert A Hauser; Archie A Silver; Michael J Mullan
Journal:  Hum Genet       Date:  2003-04-16       Impact factor: 4.132

Review 2.  Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond.

Authors:  Paul R Sanberg; Cecilia Vindrola-Padros; R Douglas Shytle
Journal:  Physiol Behav       Date:  2012-07-06

Review 3.  Nicotinic acetylcholine receptors in health and disease.

Authors:  J Lindstrom
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

Review 4.  The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.

Authors:  A D Lawrence; B J Sahakian
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

5.  Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments.

Authors:  C S Lambert; R M Philpot; M E Engberg; B E Johns; L Wecker
Journal:  Behav Brain Res       Date:  2015-06-03       Impact factor: 3.332

Review 6.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

7.  Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome : a retrospective case-note survey.

Authors:  Mazlum Copur; Baki Arpaci; Turkay Demir; Halis Narin
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 8.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

9.  Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome.

Authors:  Neal R Swerdlow; Michele J Bongiovanni; Laura Tochen; Jody M Shoemaker
Journal:  Psychopharmacology (Berl)       Date:  2006-04-01       Impact factor: 4.530

Review 10.  Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

Authors:  Maryka Quik; Danhui Zhang; Xiomara A Perez; Tanuja Bordia
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.